The significance of bremsstrahlung SPECT/CT after yttrium-90 radioembolization treatment in the prediction of extrahepatic side effects

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 2, 2012, Pages 309-315

  Ahmadzadehfar, Hojjat ^a   Muckle, Marianne ^a   Sabet, Amir ^a   Wilhelm, Kai ^a   Kuhl, Christiane ^b   Biermann, Kim ^a   Haslerud, Torjan ^a   Biersack, Hans Jürgen ^a   Ezziddin, Samer ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Bremsstrahlung; Liver metastases; Liver tumours; Radioembolization; SPECT CT

Indexed keywords

MICROSPHERE; ONDANSETRON; PROTON PUMP INHIBITOR; YTTRIUM 90; YTTRIUM;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BREMS RADIATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DUODENUM ULCER; ESOPHAGOGASTRODUODENOSCOPY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; GASTRODUODENAL ULCER; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; LIVER CONGESTION; LIVER SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; NAUSEA; PREDICTIVE VALUE; RADIATION INJURY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ADVERSE EFFECTS; ARTIFICIAL EMBOLIZATION; METABOLISM; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASMS; RADIOGRAPHY; SCINTISCANNING; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; MALE; MICROSPHERES; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; YTTRIUM RADIOISOTOPES;

EID: 84859649985     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1940-8     Document Type: Article

References (27)

1. Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, et al. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics. 2005;25 Suppl 1:S41-55. doi:10.1148/rg.25si055515. (Pubitemid 41686061)
2. Ahmadzadehfar H, Biersack HJ, Ezziddin S. Radioembolization of liver tumors with yttrium-90 microspheres. Semin Nucl Med. 2010;40:105-21. doi:10.1053/j.semnuclmed.2009.11.001.
3. Riaz A, Lewandowski RJ, Kulik LM, Mulcahy MF, Sato KT, Ryu RK, et al. Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol. 2009;29:1121-30. doi:10.1016/j.jvir.2009.05.030.
4. Tehranipour N, AL-Nahhas A, Canelo R, Stamp G, Woo K, Tait P, et al. Concordant F-18 FDG PET and Y-90 Bremsstrahlung scans depict selective delivery of Y-90-microspheres to liver tumors: confirmation with histopathology. Clin Nucl Med. 2007;32:371-4. doi:10.1097/01.rlu.0000259568.54976.bd.
5. Sebastian AJ, Szyszko T, Al-Nahhas A, Nijran K, Tait NP. Evaluation of hepatic angiography procedures and bremsstrahlung imaging in selective internal radiation therapy: a two-year single-center experience. Cardiovasc Intervent Radiol. 2008;31:643-9. doi:10.1007/s00270-008-9298-4.
6. Mansberg R, Sorensen N, Mansberg V, Van der Wall H. Yttrium 90 Bremsstrahlung SPECT/CT scan demonstrating areas of tracer/tumour uptake. Eur J Nucl Med Mol Imaging. 2007;34:1887. doi:10.1007/s00259-007-0536-9. (Pubitemid 47599065)
7. Fabbri C, Sarti G, Cremonesi M, Ferrari M, Di Dia A, Agostini M, et al. Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry. Cancer Biother Radiopharm. 2009;24:145-54. doi:10.1089/cbr.2008.0543.
8. Minarik D, Sjogreen Gleisner K, Ljungberg M. Evaluation of quantitative (90)Y SPECT based on experimental phantom studies. Phys Med Biol. 2008;53:5689-703. doi:10.1088/0031-9155/53/20/008.
9. Minarik D, Ljungberg M, Segars P, Gleisner KS. Evaluation of quantitative planar 90Y bremsstrahlung whole-body imaging. Phys Med Biol. 2009;54:5873-83. doi:10.1088/0031-9155/54/19/014.
10. Lassmann M. Dosimetry of short-ranged radionuclides. Nuklearmedizin. 2010;49 Suppl 1:S46-9.
11. Walrand S, Flux GD, Konijnenberg MW, Valkema R, Krenning EP, Lhommel R, et al. Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging? Eur J Nucl Med Mol Imaging. 2011;38 Suppl 1:S57-68. doi:10.1007/s00259-011-1771-7.
12. Ito S, Kurosawa H, Kasahara H, Teraoka S, Ariga E, Deji S, et al. (90)Y bremsstrahlung emission computed tomography using gamma cameras. Ann Nucl Med. 2009;23:257-67. doi:10.1007/s12149-009-0233-9.
13. Even-Sapir E, Keidar Z, Bar-Shalom R. Hybrid Imaging (SPECT/CT and PET/CT) - improving the diagnostic accuracy of functional/metabolic and anatomic imaging. Semin Nucl Med. 2009;39:264-75. doi:10.1053/j.semnuclmed.2009.03.004.
14. Vermeeren L, Valdes Olmos RA, Meinhardt W, Bex A, van der Poel HG, Vogel WV, et al. Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J Nucl Med. 2009;50:865-70. doi:10.2967/jnumed.108.060673.
15. Schmidt D, Szikszai A, Linke R, Bautz W, Kuwert T. Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation. J Nucl Med. 2009;50:18-23. doi:10.2967/jnumed.108.052746.
16. Patel CN, Chowdhury FU, Scarsbrook AF. Clinical utility of hybrid SPECT-CT in endocrine neoplasia. AJR Am J Roentgenol. 2008;190:815-24. doi:10.2214/AJR.07.2946. (Pubitemid 351304530)
17. Ahmadzadehfar H, Sabet A, Biermann K,Muckle M, Brockmann H, Kuhl C, et al. The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment. J Nucl Med. 2010;51:1206-12. doi:10.2967/jnumed.109.074559.
18. Sabet A, Ahmadzadehfar H, Muckle M, Haslerud T, Wilhelm K, Biersack HJ, et al. Significance of oral administration of sodium perchlorate in planning liver-directed radioembolization. J Nucl Med. 2011;52:1063-7. doi:10.2967/jnumed.110.083626.
19. Ahmadzadehfar H, Mohlenbruch M, Sabet A, Meyer C, Muckle M, Haslerud T, et al. Is prophylactic embolization of the hepatic falciform artery needed before radioembolization in patients with (99m)Tc-MAA accumulation in the anterior abdominal wall? Eur J Nucl Med Mol Imaging. 2011;38:1477-84. doi:10.1007/s00259-011-1807-z.
20. MDS Nordion. TheraSphere® Yttrium-90 Glass Microspheres: instructions for use, Ottawa: MDS Nordion. http://www.nordion.com/therasphere/physicians- package-insert/package-insert-eu-en.pdf. Accessed 28 Sep 2011.
21. D'Asseler Y. Advances in SPECT imaging with respect to radionuclide therapy. Q J Nucl Med Mol Imaging. 2009;53:343-7.
22. Gates VL, Esmail AA, Marshall K, Spies S, Salem R. Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept. J Nucl Med. 2011;52:72-6. doi:10.2967/jnumed.110.080986.
23. Lhommel R, Goffette P, Van den Eynde M, Jamar F, Pauwels S, Bilbao JI, et al. Yttrium-90 TOF PET scan demonstrates highresolution biodistribution after liver SIRT. Eur J Nucl Med Mol Imaging. 2009;36:1696. doi:10.1007/s00259-009- 1210-1.
24. Lhommel R, van Elmbt L, Goffette P, Van den Eynde M, Jamar F, Pauwels S, et al. Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres. Eur J Nucl Med Mol Imaging. 2010;37:1654-62. doi:10.1007/s00259-010-1470-9.
25. Werner MK, Brechtel K, Beyer T, Dittmann H, Pfannenberg C, Kupferschlager J. PET/CT for the assessment and quantification of (90)Y biodistribution after selective internal radiotherapy (SIRT) of liver metastases. Eur J Nucl Med Mol Imaging. 2010;37:407-8. doi:10.1007/s00259-009-1317-4.
26. Wissmeyer M, Heinzer S, Majno P, Buchegger F, Zaidi H, Garibotto V, et al. (90)Y Time-of-flight PET/MR on a hybrid scanner following liver radioembolisation (SIRT). Eur J Nucl Med Mol Imaging. 2011;38:1744-5. doi:10.1007/s00259-011-1792-2.
27. Ahmadzadehfar H, Sabet A, Reichmann K, Muckle M, Habibi E, Biersack H, et al. Imaging of Y90 distribution with PET/CT and bremsstrahlung SPECT/CT after radioembolization: A patient based study. J Nucl Med. 2011;52 Suppl 1. Abstract 92